Compounds > 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and riluzole

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with riluzole in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Studies
(riluzole)		Trials
(riluzole)		Recent Studies (post-2010) (riluzole)
9,1561875521,244153572

Protein Interaction Comparison

ProteinTaxonomy1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50)riluzole (IC50)
Sodium channel protein type 2 subunit alphaRattus norvegicus (Norway rat)4.73
Cytochrome P450 1A2Homo sapiens (human)10
Aldo-keto reductase family 1 member B1Rattus norvegicus (Norway rat)1.733
Sodium-dependent noradrenaline transporter Homo sapiens (human)1.733

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Calcerrada, MC; Catalán, RE; Martínez, AM1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and riluzole

ArticleYear
Glutamate release is involved in PAF-increased cyclic GMP levels in hippocampus.
    Biochemistry and molecular biology international, 1999, Volume: 47, Issue:3

    Topics: Animals; Cyclic GMP; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Glutamic Acid; Hippocampus; Male; Platelet Activating Factor; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Riluzole

1999